{"id":"https://openalex.org/W2042756409","doi":"https://doi.org/10.1158/1538-7445.am2013-1026","title":"Abstract 1026: Combating resistance to EGFR inhibitors: eIF4B as a novel target.","display_name":"Abstract 1026: Combating resistance to EGFR inhibitors: eIF4B as a novel target.","publication_year":2013,"publication_date":"2013-04-01","ids":{"openalex":"https://openalex.org/W2042756409","doi":"https://doi.org/10.1158/1538-7445.am2013-1026","mag":"2042756409"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2013-1026","doi":"https://doi.org/10.1158/1538-7445.am2013-1026","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-1026","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077371055","display_name":"Julie M. Madden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Madden","raw_affiliation_strings":["Wayne State University, Detroit, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wayne State University, Detroit, MI","institution_ids":["https://openalex.org/I185443292"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kelly Mueller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly Mueller","raw_affiliation_strings":["Wayne State University, Detroit, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wayne State University, Detroit, MI","institution_ids":["https://openalex.org/I185443292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033688288","display_name":"Aliccia B. Bollig-Fischer","orcid":"https://orcid.org/0000-0003-4832-9457","observed_orcids":["https://orcid.org/0000-0003-4832-9457"]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aliccia Bollig-Fischer","raw_affiliation_strings":["Wayne State University, Detroit, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wayne State University, Detroit, MI","institution_ids":["https://openalex.org/I185443292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049983845","display_name":"Paul M. Stemmer","orcid":"https://orcid.org/0000-0003-3315-9846","observed_orcids":["https://orcid.org/0000-0003-3315-9846"]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Stemmer","raw_affiliation_strings":["Wayne State University, Detroit, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wayne State University, Detroit, MI","institution_ids":["https://openalex.org/I185443292"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044158880","display_name":"Julie L. Boerner","orcid":"https://orcid.org/0000-0003-1711-4998","observed_orcids":["https://orcid.org/0000-0003-1711-4998"]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Boerner","raw_affiliation_strings":["Wayne State University, Detroit, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wayne State University, Detroit, MI","institution_ids":["https://openalex.org/I185443292"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I185443292"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"8_Supplement","first_page":"1026","last_page":"1026"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9559999704360962},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.8830000162124634},{"id":"https://openalex.org/keywords/gefitinib-resistance","display_name":"gefitinib resistance","score":0.8539999723434448},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.6570000052452087},{"id":"https://openalex.org/keywords/temsirolimus","display_name":"temsirolimus","score":0.9739999771118164},{"id":"https://openalex.org/keywords/p70s6k","display_name":"p70S6K","score":0.9369999766349792},{"id":"https://openalex.org/keywords/p90rsk","display_name":"p90RSK","score":0.996999979019165},{"id":"https://openalex.org/keywords/translational-control","display_name":"translational regulation","score":0.7049999833106995},{"id":"https://openalex.org/keywords/combination-therapy-synergy","display_name":"combination therapy synergy","score":0.7099999785423279},{"id":"https://openalex.org/keywords/phosphoproteomics","display_name":"phosphoproteomics","score":0.6940000057220459},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.8059999942779541},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.7839999794960022},{"id":"https://openalex.org/keywords/drug-resistance-mechanisms","display_name":"drug resistance mechanisms","score":0.3919999897480011}],"concepts":[{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.8390978574752808},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.7536935210227966},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6328059434890747},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.6127772927284241},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5902096033096313},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.5087655186653137},{"id":"https://openalex.org/C2776820818","wikidata":"https://www.wikidata.org/wiki/Q7699074","display_name":"Temsirolimus","level":5,"score":0.4989199638366699},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.4729587435722351},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4599640965461731},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4390374422073364},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4260757863521576},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.4258192777633667},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.41357940435409546},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4132378101348877},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.31322425603866577},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2152998447418213},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.17344319820404053},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09282425045967102},{"id":"https://openalex.org/C183713625","wikidata":"https://www.wikidata.org/wiki/Q5282002","display_name":"Discovery and development of mTOR inhibitors","level":4,"score":0.07732769846916199}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2013-1026","doi":"https://doi.org/10.1158/1538-7445.am2013-1026","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-1026","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2056756883","https://openalex.org/W7027208991","https://openalex.org/W2312375920","https://openalex.org/W2317079644","https://openalex.org/W2783537951","https://openalex.org/W3212594855","https://openalex.org/W3015650006","https://openalex.org/W2088379844","https://openalex.org/W2129728682","https://openalex.org/W4316672392"],"abstract_inverted_index":{"Abstract":[0],"Triple":[1],"negative":[2],"breast":[3],"cancer":[4,14],"(TNBC)":[5],"patients":[6,22],"suffer":[7],"from":[8],"a":[9,24,59,126,200,319,369,377,458],"highly":[10],"malignant":[11],"and":[12,29,40,71,118,156,175,195,226,241,261,317,331,340,374,376,398,414,417,428],"aggressive":[13],"that":[15,82,188,220,271,350,387,407],"currently":[16],"has":[17,66,199],"no":[18],"efficacious":[19],"therapy.":[20],"These":[21],"have":[23,43,137,186,218,247,289,337,385,420],"high":[25],"rate":[26],"of":[27,46,69,108,116,128,166,211,223,235,284,298,307,371,391,411,432,464,469],"relapse":[28],"often":[30],"develop":[31],"resistance":[32,129,452],"to":[33,55,74,121,130,144,147,179,278,291,294,310,325,354,362,423,453],"chemotherapy.":[34],"Many":[35],"TNBCs,":[36],"both":[37,224,351],"in":[38,41,113,133,140,259,266,321,357,379,408],"vitro":[39],"vivo,":[42],"elevated":[44],"levels":[45,68],"epidermal":[47],"growth":[48,373],"factor":[49],"receptor":[50],"(EGFR)":[51],"but":[52,208],"are":[53,177,394],"resistant":[54,73,178],"EGFR":[56,70,75,90,131,197,225,260,279,397,416,454],"inhibitors":[57,132,136,419],"as":[58,125,254,342,457],"monotherapy.":[60],"The":[61],"TNBC":[62,170,205,276],"cell":[63,154,171,206,322,372,381,425],"line,":[64],"BT20,":[65,173],"increased":[67],"is":[72,214],"inhibitors.":[76,400],"To":[77],"identify":[78],"the":[79,109,114,141,149,209,221,232,249,282,296,304,326,388,409,421,433,465,470],"signaling":[80,228,237],"pathways":[81,168,238],"remain":[83],"phosphorylated":[84,112,302],"after":[85],"treatment":[86,190],"with":[87,191,329,368,396],"gefitinib,":[88],"an":[89,181,192,196],"tyrosine":[91],"kinase":[92],"inhibitor":[93,194,263],"(TKI),":[94],"we":[95,104,269,313,336,384],"used":[96],"mass":[97],"spectrometry":[98],"based":[99],"phospho-proteomics.":[100],"Through":[101],"these":[102,167,404],"assays":[103],"identified":[105,248,293,338],"many":[106],"components":[107],"mTOR":[110,135,159,182,193,227,262,272,399,418],"pathway":[111,124,151],"presence":[115,410],"gefitinib":[117,330],"further":[119],"sought":[120],"explore":[122],"this":[123,212,267],"mechanism":[127,210],"TNBC.":[134],"been":[138],"investigated":[139],"clinic":[142],"due":[143],"their":[145],"ability":[146,422],"inhibit":[148],"PI3Kinase/Akt":[150],"thus":[152],"decreasing":[153,204],"survival":[155,323,429],"proliferation.":[157],"Inhibiting":[158],"also":[160],"importantly":[161],"inhibits":[162],"translation.":[163,311],"Despite":[164],"activation":[165],"our":[169,244],"lines,":[172],"MDA-MB-123,":[174],"MDA-MB-468":[176],"temsirolimus,":[180],"inhibitor.":[183],"Our":[184],"studies":[185],"found":[187,219,318],"dual":[189],"TKI":[198],"synergistic":[201],"effect":[202],"on":[203],"viability,":[207,427],"synergy":[213],"not":[215,230],"understood.":[216],"We":[217],"abrogation":[222],"does":[229],"alter":[231],"phosphorylation":[233,361,393],"status":[234],"key":[236,256],"including":[239],"MAPK":[240,413],"Akt.":[242],"Instead,":[243],"preliminary":[245],"data":[246,405],"translational":[250,434],"control":[251,435],"protein":[252],"eIF4B":[253,285,315,347,360,392,456],"potentially":[255],"fragile":[257],"point":[258],"synergy.":[264],"Therefore,":[265,312,401],"study":[268],"hypothesized":[270],"inhibition":[273,283],"will":[274],"sensitize":[275],"cells":[277],"TKIs":[280],"through":[281,437],"phosphorylation.":[286],"Small":[287],"molecules":[288,352],"yet":[290],"be":[292,355,363],"abrogate":[295,424],"function":[297],"eIF4B,":[299],"which":[300],"when":[301],"enhances":[303],"helicase":[305],"activity":[306],"eIF4A":[308],"critical":[309],"knockdown":[314],"expression":[316],"decrease":[320,327,378],"comparable":[324],"observed":[328],"temsirolimus":[332],"treatment.":[333],"In":[334],"addition,":[335],"p70S6K":[339],"p90RSK":[341],"kinases":[343],"directly":[344],"responsible":[345],"for":[346,359,473],"phosphorylation,":[348],"such":[349],"need":[353],"inactivated":[356],"order":[358],"inhibited.":[364],"This":[365],"inactivation":[366],"correlates":[367],"loss":[370],"viability":[375],"clonogenic":[380],"survival.":[382],"Lastly,":[383],"shown":[386],"downstream":[389],"functions":[390],"abrogated":[395],"taken":[402],"together":[403],"suggest":[406],"activated":[412],"AKT,":[415],"growth,":[426],"via":[430],"disruption":[431],"mechanisms":[436],"eIF4B.":[438],"Citation":[439],"Format:":[440],"Julie":[441,449],"Madden,":[442],"Kelly":[443],"Mueller,":[444],"Aliccia":[445],"Bollig-Fischer,":[446],"Paul":[447],"Stemmer,":[448],"Boerner.":[450],"Combating":[451],"inhibitors:":[455],"novel":[459],"target.":[460],"[abstract].":[461],"In:":[462],"Proceedings":[463],"104th":[466],"Annual":[467],"Meeting":[468],"American":[471],"Association":[472],"Cancer":[474,484],"Research;":[475],"2013":[476],"Apr":[477],"6-10;":[478],"Washington,":[479],"DC.":[480],"Philadelphia":[481],"(PA):":[482],"AACR;":[483],"Res":[485],"2013;73(8":[486],"Suppl):Abstract":[487],"nr":[488],"1026.":[489],"doi:10.1158/1538-7445.AM2013-1026":[490]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}